{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T01:26:07Z","timestamp":1788398767821,"version":"build-2803163510"},"reference-count":29,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Adv Pharm Technol Res"],"published-print":{"date-parts":[[2015]]},"DOI":"10.4103\/2231-4040.154543","type":"journal-article","created":{"date-parts":[[2015,4,7]],"date-time":"2015-04-07T07:28:21Z","timestamp":1428391701000},"page":"81","source":"Crossref","is-referenced-by-count":24,"title":["Comparison of amlodipine with cilnidipine on antihypertensive efficacy and incidence of pedal edema in mild to moderate hypertensive individuals: A prospective study"],"prefix":"10.4103","volume":"6","author":[{"given":"Prabhakar","family":"Adake","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"HS","family":"Somashekar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"PK","family":"Mohammed Rafeeq","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dilshad","family":"Umar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bahija","family":"Basheer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kusai","family":"Baroudi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"key-10.4103\/2231-4040.154543-1","doi-asserted-by":"crossref","first-page":"2560","DOI":"10.1001\/jama.289.19.2560","article-title":"The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: The JNC 7 report","author":"Chobanian","year":"2003","journal-title":"JAMA"},{"key":"key-10.4103\/2231-4040.154543-2","first-page":"505","article-title":"The World Health Organization MONICA Project","author":"Ecological","year":"1994","journal-title":"Int J Epidemiol"},{"key":"key-10.4103\/2231-4040.154543-3","doi-asserted-by":"crossref","first-page":"2363","DOI":"10.1001\/jama.289.18.2363","article-title":"Hypertension prevalence and blood pressure levels in 6 European countries, Canada, and the United States","author":"Wolf-Maier","year":"2003","journal-title":"JAMA"},{"key":"key-10.4103\/2231-4040.154543-4","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.1097\/HJH.0000000000000146","article-title":"Hypertension in India: A systematic review and meta-analysis of prevalence, awareness, and control of hypertension","author":"Anchala","year":"2014","journal-title":"J Hypertens"},{"key":"key-10.4103\/2231-4040.154543-5","first-page":"1003","article-title":"Residual lifetime risk for developing hypertension in middle-aged women and men: The Framingham Heart Study","author":"Vasan","year":"2002","journal-title":"JAMA"},{"key":"key-10.4103\/2231-4040.154543-6","doi-asserted-by":"crossref","first-page":"23","DOI":"10.2147\/vhrm.2008.04.01.23","article-title":"Carvedilol in hypertension treatment","author":"Stafylas","year":"2008","journal-title":"Vasc Health Risk Manag"},{"key":"key-10.4103\/2231-4040.154543-7","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1161\/CIRCULATIONAHA.106.678342","article-title":"Chronic kidney disease: Effects on the cardiovascular system","author":"Schiffrin","year":"2007","journal-title":"Circulation"},{"key":"key-10.4103\/2231-4040.154543-8","first-page":"e510","article-title":"Resistant hypertension: Diagnosis, evaluation, and treatment: A scientific statement from the American Heart Association Professional Education Committee of the Council for High Blood Pressure Research","author":"Calhoun","year":"2008","journal-title":"Circulation"},{"key":"key-10.4103\/2231-4040.154543-9","doi-asserted-by":"crossref","first-page":"761","DOI":"10.7326\/0003-4819-139-9-200311040-00011","article-title":"Pathogenesis of hypertension","author":"Oparil","year":"2003","journal-title":"Ann Intern Med"},{"key":"key-10.4103\/2231-4040.154543-10","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2147\/IBPC.S9335","article-title":"Cardio classics revisited: Focus on the role of amlodipine","author":"Owen","year":"2012","journal-title":"Integr Blood Press Control"},{"key":"key-10.4103\/2231-4040.154543-11","doi-asserted-by":"crossref","first-page":"1682","DOI":"10.1016\/S0140-6736(01)06710-1","article-title":"Assessment of frequency of progression to hypertension in non-hypertensive participants in the Framingham Heart Study: A cohort study","author":"Vasan","year":"2001","journal-title":"Lancet"},{"key":"key-10.4103\/2231-4040.154543-12","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1056\/NEJMoa003417","article-title":"Impact of high-normal blood pressure on the risk of cardiovascular disease","author":"Vasan","year":"2001","journal-title":"N Engl J Med"},{"key":"key-10.4103\/2231-4040.154543-13","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1111\/j.1524-6175.2004.03683.x","article-title":"The role of existing and newer calcium channel blockers in the treatment of hypertension","author":"Basile","year":"2004","journal-title":"J Clin Hypertens (Greenwich)"},{"key":"key-10.4103\/2231-4040.154543-14","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1001\/jama.2013.284427","article-title":"2014 evidence-based guideline for the management of high blood pressure in adults: Report from the panel members appointed to the Eighth Joint National Committee (JNC 8)","author":"James","year":"2014","journal-title":"JAMA"},{"key":"key-10.4103\/2231-4040.154543-15","first-page":"427","article-title":"Development of safer molecules through chirality","author":"Patil","year":"2006","journal-title":"Indian J Med Sci","ISSN":"https:\/\/id.crossref.org\/issn\/0019-5359","issn-type":"print"},{"key":"key-10.4103\/2231-4040.154543-16","first-page":"330","article-title":"Incidence of pedal edema formation with dihydropyridine calcium channel blockers: Issues and practical significance","author":"Weir","year":"2003","journal-title":"J Clin Hypertens (Greenwich)"},{"key":"key-10.4103\/2231-4040.154543-17","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/0014-2999(91)90620-6","article-title":"Microvascular actions of calcium channel antagonists","author":"Messing","year":"1991","journal-title":"Eur J Pharmacol"},{"key":"key-10.4103\/2231-4040.154543-18","doi-asserted-by":"crossref","first-page":"1969","DOI":"10.1097\/00004872-200310000-00026","article-title":"Heterogeneous effect of calcium antagonists on leg oedema: A comparison of amlodipine versus lercanidipine in hypertensive patients","author":"Pedrinelli","year":"2003","journal-title":"J Hypertens"},{"key":"key-10.4103\/2231-4040.154543-19","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1161\/01.HYP.35.2.621","article-title":"Amlodipine, enalapril, and dependent leg edema in essential hypertension","author":"Pedrinelli","year":"2000","journal-title":"Hypertension"},{"key":"key-10.4103\/2231-4040.154543-20","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/S1050-1738(02)00173-1","article-title":"Ca (2+) channel alpha (1B) subunit (Ca (V) 2.2) knockout mouse reveals a predominant role of N-type channels in the sympathetic regulation of the circulatory system","author":"Mori","year":"2002","journal-title":"Trends Cardiovasc Med"},{"key":"key-10.4103\/2231-4040.154543-21","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/S1566-0702(00)00203-4","article-title":"Cotransmission from sympathetic vasoconstrictor neurons: Differences in guinea-pig mesenteric artery and vein","author":"Smyth","year":"2000","journal-title":"Auton Neurosci"},{"key":"key-10.4103\/2231-4040.154543-22","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1111\/j.1527-3466.1999.tb00024.x","article-title":"Cilnidipine: Preclinical profile and clinical evaluation","author":"Uneyama","year":"1999","journal-title":"Cadiovasc Drug Rev"},{"key":"key-10.4103\/2231-4040.154543-23","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/S0014-2999(03)01546-2","article-title":"Characterization of Ca2+ current inhibition by cilnidipine using a beta-subunit antisense oligonucleotide","author":"Uchida","year":"2003","journal-title":"Eur J Pharmacol"},{"key":"key-10.4103\/2231-4040.154543-24","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1291\/hypres.26.743","article-title":"Neuronal Ca2+ channel blocking action of an antihypertensive drug, cilnidipine, in IMR-32 human neuroblastoma cells","author":"Takahara","year":"2003","journal-title":"Hypertens Res"},{"key":"key-10.4103\/2231-4040.154543-25","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1046\/j.1365-2125.2000.00299.x","article-title":"Effects of cilnidipine, a novel dihydropyridine calcium antagonist, on autonomic function, ambulatory blood pressure and heart rate in patients with essential hypertension","author":"Minami","year":"2000","journal-title":"Br J Clin Pharmacol"},{"key":"key-10.4103\/2231-4040.154543-26","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1254\/jjp.69.127","article-title":"Inhibitory effect of cilnidipine on vascular sympathetic neurotransmission and subsequent vasoconstriction in spontaneously hypertensive rats","author":"Hosono","year":"1995","journal-title":"Jpn J Pharmacol"},{"key":"key-10.4103\/2231-4040.154543-27","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1007\/BF02988529","article-title":"Cilnidipine as an agent to lower blood pressure without sympathetic nervous activation as demonstrated by iodine-123 metaiodobenzylguanidine imaging in rat hearts","author":"Sakaki","year":"2003","journal-title":"Ann Nucl Med"},{"key":"key-10.4103\/2231-4040.154543-28","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.1161\/01.HYP.33.6.1447","article-title":"Effects of amlodipine and cilnidipine on cardiac sympathetic nervous system and neurohormonal status in essential hypertension","author":"Sakata","year":"1999","journal-title":"Hypertension"},{"key":"key-10.4103\/2231-4040.154543-29","first-page":"2393","article-title":"A meta-analysis of the efficacy and safety of cilnidipine in Chinese patients with mild to moderate essential hypertension","author":"Xu","year":"2012","journal-title":"Afr J Pharm Pharmacol"}],"container-title":["Journal of Advanced Pharmaceutical Technology & Research"],"original-title":[],"language":"en","deposited":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T19:28:35Z","timestamp":1786649315000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/2231-4040.154543"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015]]},"references-count":29,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2015]]}},"alternative-id":["154543"],"URL":"https:\/\/doi.org\/10.4103\/2231-4040.154543","relation":{},"ISSN":["2231-4040"],"issn-type":[{"value":"2231-4040","type":"print"}],"subject":[],"published":{"date-parts":[[2015]]}}}